Zurcher Kantonalbank (Zurich Cantonalbank) - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$4,000
+300.0%
1,9500.0%0.00%
Q2 2022$1,000
-94.1%
1,9500.0%0.00%
Q1 2022$17,000
-67.3%
1,950
-39.6%
0.00%
Q4 2021$52,000
-20.0%
3,226
-9.2%
0.00%
Q3 2021$65,000
+35.4%
3,553
+2.7%
0.00%
Q2 2021$48,000
-2.0%
3,459
+5.0%
0.00%
Q1 2021$49,0003,2950.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders